Employers Must Accommodate Certain Opioid-Using Workers, Per ADA Guidelines

Date:

Share post:

Employers must accommodate some workers’ opioid use disorder (OUD) treatment, according to new guidance from the Equal Employment Opportunity Commission (EEOC) on the rights of opioid users under the Americans with Disabilities Act (ADA). It all comes down to whether the drugs are being used illegally or legally.

Illegal Opioid Use

If employees are using opioids illegally, their employment is not protected, according to the EEOC. Even if the employee in question hasn’t had any performance or safety problems, employers can fire them. Illegal drug use, under the ADA, falls outside of the law’s protections, ensuring that workplace safety and productivity are not compromised.

Legal Opioid Use

If opioids are being used legally, however, the situation changes. Employees who are using opioids with a prescription, are addicted to opioids, or were addicted in the past but are not currently using drugs illegally may be entitled to ADA accommodations. An example of legal opioid use could be a worker with long-term opioid prescriptions or someone participating in a medication-assisted treatment (MAT) program.

Examples of Reasonable Accommodations

The EEOC outlines that reasonable accommodations could include altered break times, flexible work schedules to accommodate treatment, a change in shift assignment, or a temporary transfer to another role. These adjustments are designed to allow employees to continue performing their jobs while receiving treatment. For instance, an employee attending MAT may need a work schedule that accommodates clinic visits.

Employer Rights and Limitations

Despite these protections, employers still have rights under the ADA. If an employee cannot perform their job safely and effectively, even with accommodations, termination may be justified. Employers are not required to lower performance standards, remove essential job duties, pay for unperformed work, or excuse illegal drug use. The balance lies in supporting recovery while ensuring the workplace remains safe and productive.

The Importance of Compliance

This guidance highlights the importance for employers to understand the nuances of the ADA and how it applies to opioid use disorder. Failure to comply could result in legal consequences, while compliance can foster a more supportive and inclusive workplace. Employers should consider implementing clear policies, offering education to supervisors, and working closely with HR and legal teams to manage accommodation requests fairly.

Workplace Impact

Accommodating workers in recovery can positively impact the workplace. Supporting employees with OUD treatment can lead to improved retention, higher productivity, and reduced stigma. It also demonstrates a company’s commitment to employee well-being, which can strengthen overall workplace culture.

Moving Forward

As opioid use disorder continues to affect communities nationwide, employers play a critical role in supporting recovery. By adhering to ADA guidelines, businesses not only comply with federal law but also contribute to broader public health efforts. The EEOC’s guidance is a reminder that while illegal drug use is not protected, employees pursuing recovery through legal treatment deserve reasonable accommodations and a fair chance to succeed.

spot_img

Related articles

Oregon’s Drug Decriminalization Creates Unfunded Mandate for Treatment Providers

Oregon's November approval of Measure 110 decriminalizing drug possession represents a landmark shift in criminal justice and addiction...

Amid Growth, Pinnacle CEO Pushes for Methadone MAT Flexibilities

The past several months have been devastating for many behavioral health providers. The COVID-19 pandemic has caused widespread...

How the Pandemic Accelerated Telehealth Adoption

The coronavirus pandemic has reshaped the behavioral health landscape, creating both challenges and opportunities for mental health care...

Virtual Pediatric Behavioral Health Provider Brightline Raises $20 Million

Brightline, a Palo Alto-based startup specializing in virtual pediatric behavioral health care, recently announced a $20 million Series...